Dr. Sharon Hausman-Cohen

ENCORE: DNA testing: Is it ready for Prime-Time? Part 1
September 27, 2023
Dr. Sharon Hausman-Cohen, Chief Medical Director of IntellxxDNA, shares her perspective on the genetic testing revolution. What’s the difference between a mutation and a SNP (single nucleotide polymorphism)? How does the IntellxxDNA test differ from, say, 23andMe? Isn’t it potentially scary to find out you have a “bad” gene, like the ApoE4 gene that’s associated with Alzheimer’s Disease risk? Can genetic risk factors be overcome with diet, exercise, and targeted supplements? IntellxxDNA pinpoints obesity genes, genes that predispose to diabetes and heart disease, macular degeneration, autoimmune disorders, thyroid problems and osteoporosis. Certain SNPs predict the likelihood of neurodegenerative diseases when exposed to environmental toxins like mercury and glyphosate. Others may dictate higher requirements for antioxidants, B vitamins, magnesium, vitamin D, and choline. Why is the IntellxxDNA test only available through health practitioners? Some critics say genetic testing is only in its infancy and not yet ready for primetime—is this mistaken? What can genomic testing tell us about remedial strategies for autism? Click HERE for part 2.

ENCORE: DNA testing: Is it ready for Prime-Time? Part 2

Dr. Hoffman continues his conversation with Dr. Sharon Hausman-Cohen, Chief Medical Director of IntellxxDNA, who shares her perspective on the genetic testing revolution. Click HERE for part 1.

The Genetics of COVID-19, Part 1
April 30, 2020
There are many factors that determine who’s more prone to hospitalization or death from coronavirus infection. But among them—and now subject to intense research—are individual genetic predispositions. Certain genes can make you more susceptible to an inflammatory cascade—cytokine storm—that presages a bad outcome in COVID-19. Integrative physician Dr. Sharon Hausman-Cohen, MD, is co-founder of IntellxxDNA, a service that helps health professionals interpret their patients’ genetic profiles. She sheds light on how variations in gene expression can influence pathways integral to viral infection. These analyses, based on saliva samples, can yield critical insights about deployment of various nutraceutical treatments—including elderberry, andrographis, astragalus, vitamins A, C, and D, zinc, fish oil and specific pro-resolving mediators (SPMs), quercetin, melatonin, EGCG, and curcumin. Click HERE for part 2.

The Genetics of COVID-19, Part 2

Dr. Hoffman continues his conversation with Dr. Sharon Hausman-Cohen, MD, co-founder of IntellxxDNA, a service that helps health professionals interpret their patients’ genetic profiles. She sheds light on how variations in gene expression can influence pathways integral to viral infection. Click HERE for part 1.